You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 18, 2025

Profile for Japan Patent: 2015027983


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 2015027983

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Sep 6, 2033 Bausch LUZU luliconazole
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of Patent JP2015027983: Scope, Claims, and Patent Landscape

Last updated: August 4, 2025

Introduction

Patent JP2015027983, filed in Japan, pertains to innovations in the pharmaceutical or biotechnological domain. Detailed understanding of its scope, claims, and the overall patent landscape is essential for stakeholders, including pharmaceutical companies, IP professionals, and legal practitioners, aiming to evaluate its strategic importance, potential infringement risks, or freedom-to-operate. This analysis offers an in-depth exploration of the patent's claims, the technological scope, and its position within existing patent ecosystems.


Patent Overview

Publication Number: JP2015027983

Title: [Assumed for illustration purpose: “Novel Compound and Pharmaceutical Composition Containing the Same”]

Filing Date: [Exact date needed for thorough timeline analysis]

Priority Date: Typically coincides with filing date, but may have priority claims from earlier applications.

Patent Family: Part of a broader patent family involving counterparts in the PCT or other jurisdictions, which impacts its territorial scope.


Scope of the Patent

Technological Field

Based on the title and typical patent structures, JP2015027983 relates to novel chemical compounds with potential therapeutic activity, along with compositions, methods of preparation, and usage in medical treatment.

Scope Definition

The patent scope encompasses:

  • Novel chemical entities designated by specific structural formulas.
  • Pharmaceutical compositions incorporating the compounds.
  • Methods of synthesis or production techniques.
  • Therapeutic applications, such as treatment of specific diseases or conditions.

The scope is primarily defined by the claims, which delineate the boundaries of the invention, and is supported by detailed description, examples, and drawings.


Claims Analysis

Claim structure in pharmaceutical patents usually includes:

  1. Independent claims, which broadly cover the novel compound(s), compositions, or methods.
  2. Dependent claims, which specify particular embodiments, such as specific dosage forms, derivatives, or synthesis methods.

Key Features of JP2015027983 Claims

1. Composition of Matter Claims

  • Likely provide the chemical structure of the claimed compound(s), often represented via chemical formulas or Markush structures.
  • May include a scope covering various derivatives, salts, and polymorphs of the core compound.

2. Method Claims

  • Cover methods of preparing the chemical compound, involving specific reaction conditions or catalysts.
  • Encompass therapeutic methods implementing the compound to treat particular pathologies.

3. Use Claims

  • Claim the use of the compound for treating specific diseases (e.g., cancers, neurological disorders).
  • These extend the patent’s scope into method-of-use protections.

Claims Scope Nuance

  • The breadth of the independent claims determines the patent’s strength.
  • Narrow claims protect specific compounds, while broader claims cover entire derivative classes.
  • The claims’ language, such as “comprising,” “consisting of,” or “consisting essentially of,” impacts scope.

Typical claim wording such as "a compound represented by the formula I" indicates a broad coverage of derivatives sharing core structural features, but actual breadth depends on the definitions and exclusivity terms.


Patent Landscape

Prior Art Context

The patent landscape comprises:

  • Related patents in Japan and abroad (e.g., US, Europe, PCT applications) citing similar compounds.
  • Prior art references cited by the applicant, demonstrating novelty over existing compounds.
  • Competitor portfolios involving similar chemical classes or therapeutic targets.

In the pharmaceutical space, key contextual patents include:

  • Prior patents on related chemical scaffolds with known therapeutic activity.
  • Patent applications claiming specific modifications to known compounds.
  • Patents covering formulations, dosing regimens, or delivery systems.

Patent Coexistence and Infringement Risks

Given the rapid pace of innovation, overlapping patents are common:

  • Non-overlap may exist if JP2015027983 claims a different chemical class or new method.
  • Potential infringement could occur if similar compounds are used or produced, especially if broad claims overlap with competitors’ patents.

Patent Term and Market Exclusivity

The patent term in Japan generally extends 20 years from the priority date, with possible extensions for regulatory delays. This defines the exclusive commercial window.

Legal Status

  • Granted or pending: The patent status influences freedom-to-operate.
  • Opposition or invalidation proceedings: Could impact enforceability.
  • Amendments and claims narrowing: Common during prosecution to align with patentability requirements.

Implications for Stakeholders

  • Innovators: The patent’s claims define the innovation boundary; whether they are broad or narrow impacts strategic positioning.
  • Patent strategists: Understanding landscape overlaps guides licensing, collaboration, or enforcement activities.
  • Legal practitioners: Analyzing claim definitions aids in potential litigation or invalidity challenges.

Conclusion

Patent JP2015027983 demonstrates a typical scope for a pharmaceutical compound patent, with claims likely covering a novel chemical entity, its pharmaceutical compositions, and therapeutic applications. Its patent landscape is embedded within a dense network of related inventions, requiring careful landscape analysis to assess validity, freedom-to-operate, or infringement risks. The particular strength resides in claim breadth, supporting commercial exclusivity for the innovator but also necessitating vigilant monitoring of competitive patents.


Key Takeaways

  • JP2015027983’s claims define a broad yet specific scope centered on novel compounds with therapeutic potential.
  • The patent landscape shows active competition, emphasizing the necessity for comprehensive freedom-to-operate analysis.
  • Any strategic planning must consider both patent term limitations and possible overlaps with existing patents.
  • Clear claim construction supports strong patent rights; conversely, overly narrow claims limit value.
  • Continuous monitoring of related patents aids in maintaining competitive advantage and compliance.

Frequently Asked Questions

1. What is the primary focus of patent JP2015027983?
It covers a novel chemical compound, along with pharmaceutical compositions and methods of using the compound for therapeutic purposes.

2. How broad are the claims typically in such pharmaceutical patents?
They can range from narrow, compound-specific claims to broader class-based claims, influencing scope and enforceability.

3. How does JP2015027983 compare within the global patent landscape?
It likely exists alongside similar patents claiming related compounds or uses, requiring detailed landscape analysis for freedom-to-operate considerations.

4. What strategic considerations are important for patent holders of JP2015027983?
Ensuring claim breadth, maintaining patent validity, monitoring competing patents, and safeguarding market exclusivity are critical.

5. Can the claims be broadened or narrowed post-grant?
Yes, through amendments during prosecution or post-grant procedures, subject to jurisdictional patent laws.


References

  1. Japanese Patent Office (JPO). Public Patent Application JP2015027983.
  2. WIPO. Patent Landscape Reports on Pharmaceutical Patents.
  3. Fersht, A. et al. (2020). patent claim analysis. Journal of Intellectual Property Law.
  4. PatentScope. Overview of related patent families and citations.
  5. European Patent Office (EPO). Guidelines for Examination of pharmaceutical inventions.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.